Volume 23, Number 2—February 2017
Low Circulation of Zika Virus, Cambodia, 2007–2016
We describe a retrospective study on circulation of Zika virus in Cambodia during 2007–2016 among patients with dengue-like symptoms and Aedes aegypti mosquitoes. Our findings suggest that Zika virus in Cambodia belongs to the Asia genotype, is endemic, has low prevalence, and has had low-level impact on public health.
Zika virus (family Flaviviridae, genus Flavivirus) is an arthropodborne virus mainly transmitted by the Aedes mosquito. Zika virus was first isolated in 1947 in Africa from rhesus macaques, and human illness was first recognized in Uganda in 1964 (1). This virus is known to cause various and nonspecific symptoms, such as fever, rash, arthralgia, headache, and conjunctivitis. In the second half of the 20th century, although the virus was detected in Africa and in Malaysia, only serologic evidence of Zika virus was reported in India, Thailand, Pakistan, Indonesia, Vietnam, and the Philippines (2). The first well-documented outbreak of Zika virus occurred in 2007 in Yap State, part of the Federated States of Micronesia (3), was followed by further outbreaks in the region (e.g., French Polynesia, New Caledonia, and Easter Island) in 2014 (2). Zika virus was detected in mainland South America in March 2015 in Brazil (4), subsequently spreading in South and Central America and most of the Caribbean over a short period (2). Before recent introduction and outbreaks of Zika virus in Singapore and Thailand (5), only sporadic autochthonous cases have been reported in Southeast Asia, whereas travel-associated cases from Zika-endemic countries have been detected in the United States, Europe, Southeast Asia, and Australia (2).
Zika virus infections have been associated recently with evidence of microcephaly related to transmission from mother to fetus during the first trimester of pregnancy (6). Moreover, other neurologic syndromes and nonvector modes of Zika virus transmission, including congenital, perinatal, and sexual, have been also described (7).
Cambodia’s National Dengue Surveillance System is a pediatric hospital–based syndromic surveillance system of suspected dengue cases managed by the Ministry of Health’s National Dengue Control Program (NDCP). Acute- and convalescent-phase samples from ≈5 patients randomly selected from each of the 5 sentinel sites in the NDCP system are collected and tested each week at Institut Pasteur du Cambodge (IPC) to ensure virologic diagnosis and surveillance (8). The first case of Zika virus infection in Cambodia was diagnosed in a 3-year-old child through community surveillance of acute fevers conducted during 2006–2010 in parallel to the NDCP sentinel system (9).
We conducted a retrospective study by using samples in our biobank: 1) acute-phase serum and supernatant from NDCP collected during January 2007–July 2016; 2) acute- or convalescent-phase serum and supernatant samples collected by private clinics for dengue diagnosis during the same period; and 3) urine from dengue-negative patients and mosquito samples included in the DENFREE study conducted in Cambodia during 2012–2013 (Technical Appendix 1). The use of samples was approved by the National Ethics Committee for Health Research of Cambodia. We also tested 3,159 Ae. aegypti female mosquitoes negative for dengue infection by quantitative real-time reverse transcription PCR (qRT-PCR). In total, 2,400 serum samples and 173 supernatants from C6/36 cell cultures of serum from the dengue surveillance system, 270 urine samples from the DENFREE study, and 3,159 mosquitoes were tested for Zika virus by qRT-PCR (10). Positive results were confirmed by using conventional RT-PCR targeting the nonstructural protein 5 gene (11) and the Trioplex qRT-PCR kit (12). DNA products of conventional RT-PCR were sent for sequencing to a commercial sequencing facility (Macrogen, Inc., Seoul, South Korea). Serum samples were also tested for Zika virus IgM, dengue virus (DENV), and Japanese encephalitis virus (JEV) by using an in-house IgM capture ELISA (MAC-ELISA) (13). The interval between the date of symptom onset and the date of sampling ranged from 0 to 26 days (n = 1,922; mean 4.13 days, 95% CI 1.66–6.6 days).
Five human serum samples were positive for Zika virus by qRT-PCR; these samples were collected in 2007 (n = 1), 2008 (n = 1), 2009 (n = 2), and 2015 (n = 1) (Technical Appendix 2). No other samples, including urine and mosquito samples, were positive. Among the 5 positive samples, 3 were also positive by conventional RT-PCR. Phylogenetic analysis of partial sequences of the nonstructural protein 5 gene from human samples (1 from 2008 and 2 from 2009) showed that all 3 strains belonged to the Asia genotype. Zika virus strain S1118214 (GenBank accession no. KX455424) isolated in 2008 clustered closest with strains from the outbreak in Micronesia (2007); 1 of the strains isolated in 2009, T0706225 (accession no. KX455425), clustered closest with outbreak or endemic strains from New Caledonia (2014), Thailand (2014), China (2016), Chile (2014), and French Polynesia (2013); and the other strain isolated from 2009, T1002464 (accession no. KX455426), clustered closest with the Cambodia strain previously isolated in 2010 (9) (Figure 1). These findings suggests that Zika virus strains in Cambodia are closely related to strains causing outbreaks in the Pacific and South America and to endemic strains circulating in Asia; however, longer sequences are needed to confirm this finding.
The serologic study of 1,992 acute-phase serum samples showed that 16 samples from 2007 (n = 2), 2008 (n = 1), 2010 (n = 2), 2012 (n = 4), and 2015 (n = 7) were positive for Zika virus IgM, with no cross-reactivity with DENV and JEV, suggesting a presumptive diagnosis of recent infection. The interpretation of the 1,976 remaining samples is distributed as follows: 146 recent DENV infections; 4 recent JEV infections; 743 recent flavivirus infections (defined by IgM detection for >2 of 3 antigens tested [DENV, JEV, and Zika virus]); and 1,087 samples negative for antibodies for any of the 3 viruses tested.
The PCR- and IgM-positive Zika virus infections we detected came from 9 provinces in north, central, and south Cambodia (Figure 2). All 5 acute-phase samples that tested positive by RT-PCR were negative by MAC-ELISA. The convalescent-phase serum samples exhibited a pattern of recent flavivirus infection in 2 samples and recent Zika virus infection in 1 sample (Technical Appendix 2). The confirmed case in 2015 was considered to be an autochthonous case because no history of recent travel to Zika-endemic areas was reported by the patient. During January–May 2016, all suspected dengue samples that tested negative for DENV were also tested for Zika virus; no cases were detected, either by serology or RT-PCR.
We show that Zika virus circulated across Cambodia during the past 10 years with low intensity and limited effect on public health. No clear explanation exists for the low detection of Zika virus by RT-PCR or by MAC-ELISA, but it might be attributable to 1) the low incidence of Zika virus, which usually causes mild disease compared with DENV, in Cambodia; 2) possible bias in the selection of viremic cases, which were mainly reported in hospitalized suspected dengue patients and therefore were more severe; 3) less than ideal timing of specimen collection for the detection of Zika virus, which has been shown to be transient and frequently low-titer and too early for detection of Zika virus IgM on acute-phase serum samples; or 4) the difficulty in interpreting MAC-ELISA results owing to the cross-reactivity of IgM between DENV and JEV, which are widely present in Cambodia.
The epidemiology of Zika virus is changing, and the risk for reintroduction in Cambodia is a real threat that should not be underestimated. Thailand, Vietnam, and Laos have reported cases since December 2015, and, local transmission has been observed recently in Singapore (5,15). Ae. aegypti and Ae. albopictus mosquitoes are widespread throughout Cambodia. The risk for reemergence or reintroduction of Zika virus should be monitored by extending the existing surveillance program to ambulatory suspected dengue patients and should be completed by a focal entomological study. Moreover, in the absence of a previously detected Zika outbreak in Cambodia, seroprevalence studies in the general population should help estimate the size of the population remaining susceptible to Zika infection.
Dr. Duong is the deputy-head of the Virology Unit at the Institut Pasteur du Cambodge. His research interests focus on diagnosis, molecular characterization, and epidemiology of arboviruses and other emerging diseases in tropical regions.
We thank the participating clinicians and hospitals for patient enrollment and management. We also thank the World Health Organization Collaborating Center for Arboviruses and Viral Hemorrhagic Fever at the Institut Pasteur de Dakar for providing us with a Zika virus strain.
Our study was funded by Institut Pasteur International Network, Actions Concertées Inter-Pasteuriennes (2014/A15) and the European Union Seventh Framework Programme (FP7/2007/2011) under Grant Agreement 282 378.
- Simpson DI. Zika virus infection in man. Trans R Soc Trop Med Hyg. 1964;58:335–8.
- Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29:487–524.
- Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536–43.
- Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21:1885–6.
- ProMED. Zika virus (44): Singapore, alert, travel advice [cited 2016 Sept 2]. http://www.promedmail.org, archive no. 20160902.4459546
- Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet. 2016;387:2125–32.
- Plourde AR, Bloch EM. A literature review of Zika virus. Emerg Infect Dis. 2016;22:1185–92.
- Huy R, Buchy P, Conan A, Ngan C, Ong S, Ali R, et al. National dengue surveillance in Cambodia 1980-2008: epidemiological and virological trends and the impact of vector control. Bull World Health Organ. 2010;88:650–7.
- Heang V, Yasuda CY, Sovann L, Haddow AD, Travassos da Rosa AP, Tesh RB, et al. Zika virus infection, Cambodia, 2010. Emerg Infect Dis. 2012;18:349–51.
- Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232–9.
- Balm MND, Lee CK, Lee HK, Chiu L, Koay ESC, Tang JW. A diagnostic polymerase chain reaction assay for Zika virus. J Med Virol. 2012;84:1501–5.
- Centers for Disease Control and Prevention. Interim guidance for Zika virus testing of urine—United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:474.
- Andries AC, Duong V, Ly S, Cappelle J, Kim KS, Lorn Try P, et al. Value of routine dengue diagnostic tests in urine and saliva specimens. PLoS Negl Trop Dis. 2015;9:e0004100.
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.
- ProMED. Zika virus (11): Americas, Europe, Asia [cited 2016 Mar 1]. http://www.promedmail.org, archive no. 20160301.4059896.